| | |
| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H24N2 |
| Molar mass | 280.415 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Ibogamine is an anti-convulsant, anti-addictive, CNS stimulant alkaloid found in Tabernanthe iboga and Crepe Jasmine ( Tabernaemontana divaricata ). [1] [2] [3] Basic research related to how addiction affects the brain has used this chemical. [4]
Like ibogaine, it has seems to have similar pharmacology. It has effects on KOR, [5] NMDAR, nAChR [6] and serotonin sites. [7] It also inhibits acetylcholinesterase and butyrylcholinesterase. [8]
Ibogamine persistently reduced the self-administration of cocaine and morphine in rats. [9] The same study found that ibogamine (40 mg/kg) and coronaridine (40 mg/kg) did not produce "any tremor effects in rats that differ significantly from saline control". While the related alkaloids ibogaine (20–40 mg/kg), harmaline (10–40 mg/kg) and desethylcoronaridine (10–40 mg/kg) were "obviously tremorgenic". [9]
Ibogamine can be prepared from one-step demethoxycarbonylation process through coronaridine. [10]
Drugs used in treatment of drug dependence (N07B) | |
|---|---|
| Nicotine dependence |
|
| Alcohol dependence | |
| Opioid dependence | |
| Benzodiazepine dependence |
|
| Tryptamines |
|
|---|---|
| 4-Hydroxytryptamines and esters/ethers |
|
| 5-Hydroxy- and 5-methoxytryptamines |
|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|
| Stimulants |
|
|---|---|
| Depressants |
|
| Hallucinogens |
|
| Entactogens |
|
| Psychiatric drugs |
|
| Others |
|